11/26
02:10 pm
krys
Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
08:28 am
krys
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/26
08:00 am
krys
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference
Low
Report
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference
11/19
01:42 pm
krys
Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT [Yahoo! Finance]
Low
Report
Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT [Yahoo! Finance]
11/16
09:01 am
krys
Krystal Biotech: Vyjuvek Gene Therapy Well Positioned For Growth [Seeking Alpha]
Low
Report
Krystal Biotech: Vyjuvek Gene Therapy Well Positioned For Growth [Seeking Alpha]
11/14
01:15 pm
krys
Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Krystal Biotech (NASDAQ:KRYS) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/4
08:44 am
krys
Krystal Biotech (NASDAQ:KRYS) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Krystal Biotech (NASDAQ:KRYS) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
11/4
08:42 am
krys
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $216.00 to $220.00. They now have a "buy" rating on the stock.
Medium
Report
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $216.00 to $220.00. They now have a "buy" rating on the stock.
11/3
07:00 am
krys
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
Low
Report
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results
10/21
08:00 am
krys
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
Low
Report
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
10/17
08:12 am
krys
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Bank of America Corporation from $182.00 to $255.00. They now have a "buy" rating on the stock.
Low
Report
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Bank of America Corporation from $182.00 to $255.00. They now have a "buy" rating on the stock.
10/17
08:06 am
krys
Krystal Biotech (NASDAQ:KRYS) was given a new $224.00 price target on by analysts at Guggenheim.
Low
Report
Krystal Biotech (NASDAQ:KRYS) was given a new $224.00 price target on by analysts at Guggenheim.
10/14
08:11 pm
krys
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis [Yahoo! Finance]
Low
Report
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis [Yahoo! Finance]
10/14
08:00 am
krys
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis
Low
Report
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis
10/1
05:36 am
krys
Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? [Yahoo! Finance]
Low
Report
Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? [Yahoo! Finance]
9/15
02:38 pm
krys
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $240.00 price target on the stock.
Low
Report
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $240.00 price target on the stock.
9/15
09:24 am
krys
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label [Yahoo! Finance]
Medium
Report
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label [Yahoo! Finance]
9/15
08:00 am
krys
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
Medium
Report
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
9/12
08:56 am
krys
TSCM U.S. Small Cap Growth Strategy Reduced Its Position in Krystal Biotech (KRYS) [Yahoo! Finance]
Low
Report
TSCM U.S. Small Cap Growth Strategy Reduced Its Position in Krystal Biotech (KRYS) [Yahoo! Finance]